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Stroke survivors increasingly use the internet to access health information. The aim of this study was 
to evaluate the quality of online information about anticoagulant and antiplatelet medication in 
stroke. 100 online information sources and 50 online news articles about anticoagulants and 
antiplatelets after stroke were accessed using Google in June-July 2016. Readability, overall quality, 
and language about prevention, risk, emotive terms, and shared decision-making were evaluated 
using SMOG and DISCERN tools. Most online information was from national health service (27/100) 
or charitable (24/100) sources, or from tabloid newspapers’ websites (25/50). Median reading age 
for materials was 17-18 years. Quality scores were typically 3/5 with only 5 of 16 criteria scoring 
highly. Stroke risk reduction was typically described in absolute terms with little use of numerical or 
graphical data. Emotive language was frequently used, particularly in news articles. Shared decision-
making was supported mainly by materials from charitable sources. This study has shown that online 
information about anticoagulant and antiplatelet medication after stroke requires high levels of 
literacy, and is often unreliable, poor quality and emotionally laden. People working with stroke 
survivors should facilitate access to accurate, unbiased and readable materials to promote shared 
decision making about medications. 
  





In long-term conditions, such as after stroke, it is estimated that around 50% of prescribed 
medication doses are either omitted or taken incorrectly [1]. After ischaemic stroke, several long-
term medications, including either antithrombotic medications (or, for those with atrial fibrillation or 
other indications, anticoagulant medication), antihypertensives, and statins, are recommended to 
reduce the risk of stroke recurrence [2,3]. Medication adherence and persistence may be particularly 
challenging after stroke, however, because of difficulties caused by post-stroke physical and 
cognitive disability, particularly for people with more severe stroke [4], as well as the lack of 
immediate and obvious efficacy of essentially preventive medications. 
It is vital that information materials about these stroke prevention medications are readable and 
appropriately presented for the layperson. Stroke disproportionately affects older people and those 
from less-advantaged socioeconomic groups [5], who are likely to have lower general and health 
literacy than the general population [6], and poor health literacy itself is known to be associated 
with higher all-cause mortality [7]. In addition, stroke survivors may have cognitive or 
communication difficulties [8,9] and many have multiple comorbidities requiring a number of other 
medications [10]. If stroke survivors cannot readily access easy to read, accurate and appropriately 
written information, their ability to be an active participant in their own treatment and care will be 
compromised. This may affect medication persistence and adherence. 
Whilst health care providers often provide verbal or printed written information about medications 
to supplement the standard ‘patient information sheet’ which is provided with the medication 
packet, stroke survivors and carers, in common with people experiencing other medical conditions, 
are increasingly turning to the internet, alongside other lay media sources (e.g. print and broadcast 
media) for additional information about their treatment options [11,12]. It is thus very important 
that online materials are written and presented comprehensibly for the layperson, and are accurate, 
unbiased, based on current evidence and guidelines, and designed to promote shared decision-




making, especially as laypersons may have limited information-evaluation skills in relation to health 
information [11]. Few studies, however, have examined the readability and quality of online 
information about stroke. One study has found that online information about stroke (but not 
specifically about medication) is generally too complex for the layperson, but only examined 
readability rather than the reliability or quality of information [13]. Another study of online and 
other materials to communicate risk about thrombolysis for acute stroke also found that the 
information provided was too complex and often did not promote shared decision-making[14]. A 
further study [15] of websites specifically about vitamin K antagonist (warfarin/coumarin) therapy 
(which is commonly prescribed for a number of clinical problems, including stroke prevention) found 
that materials were accurate, but required high literacy levels. However, this study, like others, did 
not examine a wide range of sources, nor did it explore the extent to which the materials promoted 
shared decision-making. This is particularly important, given that laypersons who are searching the 
internet for health information may well be doing so in order to improve their ability to engage 
knowledgeably in decisions about their treatment and care. No studies to date have 
comprehensively examined online information about stroke, or have analysed the readability of 
information about stroke prevention medication. In addition, many studies have focused only on 
sources of information which have prima facie credibility, such as those produced by established 
health providers, rather than examining all relevant sources which are available to the lay Internet 
user. In particular, the content and readability of online news articles has not been examined, yet 
such articles may be a common source of lay information that is accessed opportunistically by stroke 
survivors and carers. The evaluation of online news articles also gives a snapshot of the quality and 
scope of the content of traditional broadcast and print media, given that articles are often hosted 
across both online and traditional media platforms.  
The aim of this study was to review the readability and quality of online materials and online news 
articles which were likely to be accessed by patients or other laypeople in relation to secondary 
stroke prevention. The review focused on two drug classes: antiplatelets and oral anticoagulants, in 




relation to stroke risk reduction rather than their effects for other conditions (e.g. venous 
thromboembolism).  
The main objectives were to evaluate: 
1. The readability of a sample of online materials 
2. The quality and reliability of the materials 
3. How the benefits and risks of the medications were presented. 
Methods 
Searches were conducted using Google, which is the most trusted [16] and widely used search 
engine in the world [16,17], and which attracts approximately 100 billion web searches per month 
[17]. The Google UK search engine was used to identify materials that would be accessed during a 
typical online search from the UK, and separate searches were carried out using Google News to 
identify materials that were available via online news media outlets. Five separate searches were 
conducted for both Google UK and Google News. Search terms were stroke medications; warfarin 
after stroke; clopidogrel after stroke; anticoagulants after stroke; and antiplatelets after stroke. 
These terms were chosen to represent typical searches that a person after stroke, or their family 
member, might conduct, and included the generic names for the most commonly prescribed 
anticoagulant (warfarin) and antiplatelet drug (clopidogrel), as well as materials discussing 
anticoagulants, antiplatelets, and medications in general after stroke. The first 20 eligible websites 
for Google UK, and top 10 for Google News, which satisfied the inclusion and exclusion criteria were 
included. These numbers were chosen to mimic a realistic number of search results that a lay user 
might access, representing the first one or two pages of search results on a typical desktop 
computer. Google UK searches were not time-limited, but for Google News searches we initially 
limited to the past 6 months. For two of the searches, “Clopidogrel after stroke” and “Antiplatelets 
after stroke”, the time period was extended to 24 months and 12 months respectively in order to 




obtain 10 relevant articles for each search.   The Google UK search was conducted first, followed by 
the Google News search; any duplicates across the two searches were then excluded from the 
Google News search and replaced with the next item that met the criteria. This was done because 
most lay internet users would be likely to conduct searches using Google rather than Google News, 
but the additional Google News search gave a snapshot of content on broadcast and print media. 
Searches were carried out in July 2016 using a desktop computer linked to a UK university 
mainframe, by a student investigator (Author 2) using a student login. The student had not 
previously studied or worked in the field of stroke, or medication. Due to the way that Google, in 
common with other search engines, operates, this search strategy gave a non-reproducible 
‘snapshot’ of the most commonly accessed information that was available at the time of the search; 
the identical search conducted at any other time, even with appropriate date limits, would generate 
at least some different results. 
Searches excluded: 
 Advertisements and other promoted materials 
 Materials clearly intended primarily for health professionals or academic use (e.g. training 
materials, academic journal articles). When the search led to a website primarily for 
professionals but with a readily accessible link to information clearly labelled for laypersons, 
the latter was included. Where no such publicly focused information was linked, the 
resource was excluded. 
 Materials written by stroke survivors, carers or other service users without any apparent 
professional input e.g. blogs and chatroom discussions 
 Materials not written in English 
All materials were saved from their source at the time of the search and classified according to the 
type of source. 




Materials were evaluated using the following methods: 
1) Readability  
The ‘Simple Measure Of Gobbledygook’ (SMOG) score [18], which is widely used in the assessment 
of health literature [19], was used to assess the number of years in education required to 
understand a sample of text. SMOG scores were calculated by copying and pasting the text into an 
electronic SMOG score calculator [20]. This calculated readability using sentence length and number 
of polysyllabic words, which was then converted into a ‘grade score’, denoting the number of years 
in full-time education that would be required to understand the text (broadly equivalent to 
chronological age minus 6 years). The SMOG tool selected provided a grade score which meant that 
someone of this reading ability would be able to fully comprehend the text, rather than merely 
understanding its general meaning. This was important since even minor misinterpretations or 
misreadings of written material about medication could have serious consequences for health. 
 
2) Quality and reliability 
Relevant text was rated against the DISCERN criteria [21], a 15-item instrument for judging the 
quality of written consumer health information on treatment choices. The DISCERN instrument has 
two main sections: reliability, and quality of information, plus an overall rating (see Table III). For 
section 2 of the DISCERN tool (quality of information), text was benchmarked against the then 
current edition of the UK Clinical Guideline for Stroke [22]. An overall score was given for each 
source using a 5-point scale in line with DISCERN user guidance [21]. A score of 5 was given if the 
quality criterion was completely fulfilled; scores of 4, 3 or 2 were given if the criterion was partially 
fulfilled; a score of 1 was given if the quality criterion was not fulfilled at all. 
3) Presentation of risks and benefits  




The DISCERN tool [21] includes only a limited overall assessment of whether the risks and benefits of 
treatment are described. As this is particularly pertinent when considering the use of preventive 
medication, a more detailed evaluation was conducted of the tone and content of this information in 
relation to locus of decision-making (e.g. whether the doctor, patient or both should decide whether 
to start the medication), implied certainty or uncertainty (e.g. whether the materials discussed the 
benefits of medication in terms of definitely ‘preventing’ or  possibly ‘reducing the risk of’ another 
stroke), presentation of risks and benefits using numerical, verbal or pictorial/graphical methods, 
and emotive language.  
Inclusion of final sources was based on the criteria described in the methods and was agreed by two 
researchers (RE and JG). Data extraction included all material within each source that pertained 
directly to antiplatelets and/or anticoagulants after stroke. Material that discussed other 
medications or treatments, or other aspects of life after stroke, was not extracted. Data extraction 
and ratings were performed by RE. A 10% sample was rescored by JG with +/- 10% agreement. 
Findings 
Materials accessed were from a variety of different types of source (see table I). Of the 100 websites, 
the British National Health Service (NHS) was the dominant source (27/100), either from the central 
website NHS Choices or from individual NHS provider organisations (e.g. hospital trusts). The 
charitable sector (e.g. The Stroke Association) contributed 24/100 of all sites included. 26/100 items 
were from types of source also found in the News search. 
Of the 50 news items, 25 were from online versions of national tabloid newspapers; the remainder 
were from health websites and a range of other media outlets. 
Typically, materials had SMOG scores that required a reading age of 17-18 years for full 
comprehension. For websites, the mean SMOG score was 14.5 (range 8.5-57.6). For news items, the 
mean SMOG score was 14.6 (range 11.2-21.8). (See Table II.) 




Quality appraisal of the materials is summarised in table III using the DISCERN criteria. Quality 
tended to be lower for news items (mean overall rating 2.67, range 1-5) than for websites (3.13, 
range 1-5). For all 15 DISCERN criteria there was at least one maximum ‘5’ score for websites, but for 
6/15 criteria there were no news articles scoring 5. Three items for the websites and seven items for 
the news items had mean scores of 2 or less. Two criteria (numbers 5 and 9) scored particularly 
poorly across both websites and news items: details of when the information reported was 
produced, and information on how the treatment works. For the websites, the highest mean 
DISCERN scores were seen for health charity website materials, from organisations such as the 
Stroke Association (www.stroke.org.uk) and the British Heart Foundation (www.bhf.org.uk), with a 
mean DISCERN score of 3.56 (range 3-4). NHS websites also had a higher mean DISCERN score (3.35, 
range 2-5) than the overall score of 3.13 for all websites. 
Presentation of risk, certainty, and emotive language is summarised in table IV. The benefits and 
risks of medication were overwhelmingly described in very general, non-numeric terms (e.g. ‘will 
help prevent a stroke’). Where numerical values were given, this was most often expressed as 
relative risk reduction. Only five of the websites, and none of the news items, used visual depictions 
of risk and risk reduction such as graphs or pictograms. 
Although the majority of websites, notably those from the charitable sector, directly referred to 
shared decision making, typically with statements that the individual should discuss the suitability of 
the medication with their doctor, it was notable that other treatment options (including the option 
of no treatment) were very rarely mentioned. Some other sources, including many from the NHS, 
indirectly implied that the individual had little or no choice or agency about whether or not to 
commence and continue the medication, via their use of terms such as ‘must’ or ‘should’, and they 
also generally lacked any mention of shared decision making or patient autonomy. 16% of web 
sources and 40% of news articles used at least one instance of emotive language. These illustrated 
either benefit or harm with terms such as ‘slash’, dramatic’, and ‘killer’. 





This study shows that the interpretation of web-based information about anticoagulant and 
antiplatelet medication after stroke requires high levels of general literacy. While there are some 
high quality information sources, much of the available information is unreliable, of poor quality, 
does not promote shared decision making, and is sometimes emotionally laden. Perhaps 
unsurprisingly, news articles in particular are prone to using emotive language. 
The overall highest quality sources tended to be from charities’ websites such as the Stroke 
Association. These materials were typically easier to read than others, were based on accurate 
information, and took into account the need for patients’ views and preferences to be considered in 
treatment choices. There were, however, notable examples of poorer quality material from some 
other sources which the layperson might expect to be authoritative, such as NHS providers. 
Although the information that such sources provided was generally accurate, in some cases the 
language was over-technical and hard to read; other sources used a paternalistic tone and language, 
which did not foster shared decision-making. Often, risks and benefits were mentioned but with no 
numerical information, and very few materials included graphical or pictorial illustrations to aid 
understanding. 
Although we did not search specifically for ‘easy-read’ materials designed for comprehension by 
people with cognitive or language difficulties, none were retrieved by our general searches. The 
language of most of the commonly accessed materials was too complex for the general reader, 
especially those with limited health literacy, and would be likely to present particular challenges for 
people with cognitive or language difficulties. This is a particular concern given that many stroke 
survivors have some degree of cognitive and/or language difficulties. 
Our study has several limitations. Although we included materials from any country, our search was 
confined to materials written in English and to those which were accessed via a UK web browser.  




We excluded advertisements and materials clearly designated for professional use, but it may be 
that laypersons would in fact access at least some of these materials. In the UK, direct advertising of 
prescription medications to laypeople is not permitted, and it is possible that a similar study in a 
country where it is (such as the USA) might yield very different findings. Our search strategy 
provided only a one-time snapshot of the available material that a layperson might access. We did 
not evaluate the materials blind, and our knowledge of the provenance of the materials may be a 
source of bias. We did not attempt to examine how stroke survivors or their carers actually 
understood and used these materials, and it is possible that at least some people, particularly those 
who are well-versed in using online materials, are adept at identifying and appraising higher- and 
lower-quality sources. 
Our study concurs with previous findings [13,14] that online information for laypeople about stroke 
is suboptimal. Since our review was conducted, a further study of online literature about heart 
failure [23] has identified similar issues with the readability and quality of materials.  Although the 
provision of written information, including web-based sources, is only one element in supporting 
stroke survivors to make and continue with treatment choices, it is nonetheless an important one. 
Our study suggests, however, that it may be extremely challenging for stroke survivors to access 
easy to read, accurate and appropriately written information via the Internet that will assist them to 
participate in informed decisions about their treatment options in secondary prevention. This may 
affect uptake, persistence and adherence to these medications.   
This study suggests that practitioners working with stroke survivors in primary and secondary care 
settings should ensure that they provide guidance and support to enable access to appropriate 
printed or Internet-based materials. It is clearly insufficient to expect stroke survivors and carers to 
rely on the readability and quality of the materials that they can access via the Internet without this 
guidance. Particular attention needs to be paid to the presentation of numerical data on risks and 
benefits in accessible forms, such as pictorial or graphical information. The limited emphasis on 




shared decision making is also an area of concern. Over-directive or emotive language is common, 
particularly in news items, and should be avoided. Practitioners, health care organisations and other 
information providers could make use of the SMOG and DISCERN tools to appraise any materials 
they provide or are developing. This would be optimally achieved in close collaboration with service 
user-led organisations and stroke survivors and carers themselves.  
In future studies, consideration should be given to evaluating materials ‘blind’ to minimise bias. 
Further research could also usefully examine how well these materials are understood by stroke 
survivors and carers in practice, and develop ways of helping them to evaluate materials in order to 
base their treatment choices on accurate and unbiased information.  
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Table I: Materials included classified by type of source. 
Type of source Websites (n=100) News items (n=50) 
NHS Choices 7 - 
Other NHS sources 20 - 
Other health provider 
organisations 
2 - 
Charitable sector 24 - 
National Institute for Health 
and Care Excellence 
6 - 






Professional bodies 4 - 
Tabloid (national) 6 25 
Health website 8 10 
News agency 1 4 
Web based news source 4 3 
Local news website 1 3 
Broadsheet (national) 3 2 
Broadcast media e.g. British 
Broadcasting Corporation  
2 2 
Magazine 1 1 
 
 








 Websites (n=100) News items (n=50) 
Average SMOG score 14.49 14.62 
Median SMOG score  13.36 14.41 
Highest SMOG score  57.63 21.84 
Lowest SMOG score  8.53 11.21 
Average age of understanding  18.49 18.62 
Median age of understanding  17.36 18.41 











Section 1: Reliability    
1. Are the aims clear?  4 (2-5) 3 (2-4) 
2. Does it achieve its aims?  4 (1-5) 4 (3-5) 
3. Is it relevant?  4 (2-5) 4  (2-5) 
4. Is it clear what sources of information were used to 
compile the publication (other than the author or 
producer)?  
2 (1-5) 3 (1-4) 
5. Is it clear when the information used or reported in 
the publication was produced?     
2 (1-5) 1 (1-4) 
6. Is it balanced and unbiased? 4 (2-5) 4 (2-5) 
7. Does it provide details of additional sources of 
support and information?  
3 (1-5) 2 (1-4) 
8. Does it refer to areas of uncertainty?  4 (1-5) 2 (1-5) 
Section 2: How good is the quality of the information on 
treatment choices?  
  
9. Does it describe how each treatment works?  2 (1-5) 1 (1-3) 
10. Does it describe the benefits of each treatment?  3 (1-5) 3 (1-5) 
11. Does it describe the risks of each treatment?  3 (1-5) 2 (1-5) 




12. Does it describe what would happen if no treatment 
is used? 
3 (1-5) 4 (1-5) 
13. Does it describe how the treatment choices affect 
overall quality of life?  
3 (1-5) 3 (1-5) 
14. Is it clear that there may be more than one possible 
treatment choice?  
3 (1-5) 2 (1-3) 
15. Does it provide support for shared decision-making?  3 (1-5) 2 (1-5) 
Section 3: Overall rating of the publication   
Based on the answers to all of the above questions, rate the 
overall quality of the publication as a source of information 












Table IV: Presentation of risk, certainty and emotive language in websites and news sources 
 
Google UK sources: mean 
occurrences across 100 
sources (% of sources)  
News items: mean occurrences 
across 50 sources  (% of 
sources)  
Risks Presented (e.g. 
adverse drug reactions) 
  
In words  3.75 (73) 1.84 (62) 
As relative risk  0.28 (14) 0.04 (4)  
As absolute frequency  0.06 (4)  0.00 (0) 
As number needed to harm 
(NNH)  
0.44 (14) 0.00 (0) 
As graph or pictogram  0.18 (4)  0.00 (0) 
Benefits Presented (e.g. 
reduction in stroke risk) 
  
In words only  2.46 (86) 2.40 (90) 
As relative risk reduction 0.34 (15) 0.60 (32) 
As absolute frequency  0.34 (6) 0.04 (4) 
As number needed to treat 
(NNT)  
0.05 (6) 0.00 (0)  
As graph or pictogram 0.29 (5)  0.00 (0) 
Discussion of decision to 
take medication or not 
  
‘Must’ take medication  1.3 (46) 0.3 (20) 
‘Should’ take medication  2.64 (59) 1.2 (68) 
Shared decision making  2.26 (57) 0.72 (40) 




‘Will’ prevent or reduce risk  2.28 (78) 1.22 (64) 
‘May’ prevent or reduce risk  0.73 (36) 0.82 (54) 
Incidence of emotive 
language  
0.34 (16) 0.68 (40) 
Examples of emotive 
language (capitalisations in 
original sources) 
"Aspirin a day could 
dramatically cut cancer risk, 
says biggest study yet" 
 
"ROUTINE DRUG 
COMBINATION IS A KILLER" 
“Taking aspirin after a mini 
STROKE can slash risk of major 
one by EIGHTY per cent” 
 
"An aspirin a day keeps death at 
bay" 
 
